Evaluation of genotype MTBDRplus V2 and genotype MTBDRsl V2 for the diagnosis of extrapulmonary tuberculosis in India-Reference-Cited by-同舟云学术

Evaluation of genotype MTBDRplus V2 and genotype MTBDRsl V2 for the diagnosis of extrapulmonary tuberculosis in India

Published:2020-12 Issue: Volume:125 Page:102014
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Singh Binit Kumar,Sharma Rohini,Chaubey Jigyasa,Gupta Nitin,Soneja Manish^ORCID,Jorwal Pankaj,Nischal Neeraj,Biswas Ashutosh,Wig Naveet,Sarin Sanjay,Ramachandran Ranjani

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference19 articles.

1. Extra-pulmonary tuberculosis: an overview;Golden;Am Fam Physician,2005

2. Use of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates;Hillemann;J Clin Microbiol,2005

3. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India;Yadav;PloS One,2013

4. Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis. HasnainSE;Singh;PloS One,2017

5. GenoType MTBDRplus VER 2.0 instructions for use;LifeScience,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Performance of Different Laboratory Methods for the Detection of Extrapulmonary Tuberculosis;Microorganisms;2023-04-19

2. MTBDRplus and MTBDRsl for simultaneous diagnosis of gastrointestinal tuberculosis and detection of first‐line and second‐line drug resistance;Journal of Gastroenterology and Hepatology;2023-01-30

3. Epidemiology of extrapulmonary tuberculosis in central Guangxi from 2016 to 2021;European Journal of Clinical Microbiology & Infectious Diseases;2022-11-29

4. Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis;Clinica Chimica Acta;2022-08